BBO-10203, a First-in-class, Orally Bioavailable, Selective Covalent Small Molecule That Inhibits RAS- Driven PI3Kalpha Activity Without Affecting Glucose Metabolism
CANCER RESEARCH(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH(2024)